Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

Basit Öğe Kaydı
dc.authorid0000-0003-1514-1685
dc.authorid0000-0002-8909-2102
dc.contributor.authorAygen, Bilgehan
dc.contributor.authorDemir, Ahmet Muzaffer
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorKarabay, Oguz
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorKoksal, Aydin Seref
dc.contributor.authorKoksal, Iftihar
dc.date.accessioned2025-05-10T19:59:11Z
dc.date.issued2018
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractThis consensus report includes expert opinions and recommendations regarding the screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before the treatment in patients who will undergo immunosuppressive therapy due to the risk of hepatitis B reactivation emergency. To increase awareness regarding the risk of hepatitis B reactivation in immunosuppressive patients, academicians from several university health research and training centers across Turkey came together and discussed the importance of the subject, current status, and issues in accordance with the current literature data and presented solutions.
dc.identifier.doi10.5152/tjg.2018.18263
dc.identifier.endpage269
dc.identifier.issn1300-4948
dc.identifier.issn2148-5607
dc.identifier.issue3
dc.identifier.pmid29755010
dc.identifier.scopus2-s2.0-85055830494
dc.identifier.scopusqualityQ3
dc.identifier.startpage259
dc.identifier.trdizinid289048
dc.identifier.urihttps://doi.org/10.5152/tjg.2018.18263
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/289048
dc.identifier.urihttps://hdl.handle.net/20.500.14730/13777
dc.identifier.volume29
dc.identifier.wosWOS:000440300700002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Journal of Gastroenterology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectHepatitis B
dc.subjectimmunosuppressive therapy
dc.subjectreactivation risk
dc.subjectantiviral prophylaxis
dc.titleImmunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
dc.typeReview

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
13777.pdf
Boyut:
145.11 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu